Rite Aid Considers Second Bankruptcy Amid Ongoing Financial Struggles

Rite Aid, the U.S. pharmacy chain, is reportedly weighing another Chapter 11 bankruptcy filing after its recent financial restructuring failed to stabilize the business, according to the Wall Street Journal. The company had emerged from bankruptcy in 2023 as a private entity, having closed hundreds of stores and sold off assets including its pharmacy benefit manager, Elixir.

Despite these efforts, Rite Aid continues to face severe financial challenges. Sources familiar with the matter told the WSJ that the company is also exploring the potential sale of parts or all of its operations to avoid another bankruptcy. However, if no buyers emerge—either inside or outside of court protection—further liquidation of its remaining stores may be unavoidable.

The Pennsylvania-based retailer initially filed for Chapter 11 in October 2023 after posting $750 million in losses on $24 billion in revenue for the fiscal year ended March 2023. At the time, it operated around 2,000 pharmacy locations. As part of its restructuring, Rite Aid negotiated settlements with key stakeholders, including drug distributor McKesson (NYSE: MCK), creditors, and lenders.

The company has not yet commented publicly on the latest reports. The looming possibility of another bankruptcy highlights the ongoing struggles traditional pharmacy chains face amid rising competition, legal liabilities, and shifting consumer behavior.

Rite Aid’s potential repeat bankruptcy signals continued volatility in the retail pharmacy sector. While restructuring allowed the company to reduce debt and scale down operations, it appears insufficient to ensure long-term viability. Investors and industry observers will closely watch for updates, as the company's future remains uncertain.